Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:718950rdf:typepubmed:Citationlld:pubmed
pubmed-article:718950lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:718950lifeskim:mentionsumls-concept:C0001443lld:lifeskim
pubmed-article:718950lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:718950lifeskim:mentionsumls-concept:C1151015lld:lifeskim
pubmed-article:718950lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:718950pubmed:issue2lld:pubmed
pubmed-article:718950pubmed:dateCreated1979-2-23lld:pubmed
pubmed-article:718950pubmed:abstractTextIncubation of bovine adrenocortical membranes with corticotropin and 5-guanylylimidodiphosphate produced a state of adenylate cyclase (ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1) with maximal catalytic activity and an increased sensitivity to inhibition by adenosine. Due to metabolism of adenine nucleotides during adenylate cyclase assays a quantitative assessment of the nature of this inhibition was not possible. However, when determined at 0.2--1.0 mM MgATP2-, half-maximal inhibition of the basal and maximally active states of the enzyme was observed at adenosine concentrations of 210--330 and 70--90 micrometer, respectively. The inhibition appeared to be partially competitive, suggesting that the nucleoside may act as an allosteric negative effector which reduces the affinity of the active site for substrate. Adenosine was 5--6 times more potent as an inhibitor of adrenal adenylate cyclase than 2-chloroadenosine. Adenosine deaminase abolished the inhibitory effect of the nucleoside, whilst theophylline had no effect on activity either in the absence or presence of adenosine.lld:pubmed
pubmed-article:718950pubmed:languageenglld:pubmed
pubmed-article:718950pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:718950pubmed:citationSubsetIMlld:pubmed
pubmed-article:718950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:718950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:718950pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:718950pubmed:statusMEDLINElld:pubmed
pubmed-article:718950pubmed:monthOctlld:pubmed
pubmed-article:718950pubmed:issn0006-3002lld:pubmed
pubmed-article:718950pubmed:authorpubmed-author:GlynnPPlld:pubmed
pubmed-article:718950pubmed:authorpubmed-author:CooperD MDMlld:pubmed
pubmed-article:718950pubmed:issnTypePrintlld:pubmed
pubmed-article:718950pubmed:day12lld:pubmed
pubmed-article:718950pubmed:volume526lld:pubmed
pubmed-article:718950pubmed:ownerNLMlld:pubmed
pubmed-article:718950pubmed:authorsCompleteYlld:pubmed
pubmed-article:718950pubmed:pagination605-12lld:pubmed
pubmed-article:718950pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-A...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-C...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-A...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-A...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-A...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-N...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-C...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-B...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-A...lld:pubmed
pubmed-article:718950pubmed:meshHeadingpubmed-meshheading:718950-A...lld:pubmed
pubmed-article:718950pubmed:year1978lld:pubmed
pubmed-article:718950pubmed:articleTitleInhibition of bovine adrenocortical adenylate cyclase activity by adenosine.lld:pubmed
pubmed-article:718950pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:718950pubmed:publicationTypeComparative Studylld:pubmed